Jesduvroq

Active Ingredient(s): Daprodustat
FDA Approved: * February 1, 2023
Pharm Company: * GLAXOSMITHKLINE
Category: Anemia
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Jesduvroq 1 mg Oral Tablet, Film Coated
NDC: 0173-0897
Labeler:
Glaxosmithkline LLC
Jesduvroq 2 mg Oral Tablet, Film Coated
NDC: 0173-0903
Labeler:
Glaxosmithkline LLC
Jesduvroq 4 mg Oral Tablet, Film Coated
NDC: 0173-0906
Labeler:
Glaxosmithkline LLC
Jesduvroq 6 mg Oral Tablet, Film Coated
NDC: 0173-0911
Labeler:
Glaxosmithkline LLC
Jesduvroq 8 mg Oral Tablet, Film Coated
NDC: 0173-0914
Labeler:
Glaxosmithkline LLC